NewGenIvf Group (NASDAQ:NIVF) Shares to Reverse Split on Monday, October 12th

NewGenIvf Group Limited (NASDAQ:NIVF) shares are going to reverse split on the morning of Monday, October 12th. The 1-4 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, October 11th.

NewGenIvf Group Stock Performance

Shares of NewGenIvf Group stock traded down $0.02 during trading on Thursday, reaching $0.08. The stock had a trading volume of 18,737,952 shares, compared to its average volume of 75,441,272. The stock has a fifty day moving average price of $1.12 and a two-hundred day moving average price of $6.93. NewGenIvf Group has a 52 week low of $0.06 and a 52 week high of $1,539.00.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Wednesday, October 7th. The company reported ($13.32) earnings per share for the quarter. The firm had revenue of $0.96 million during the quarter. Equities analysts predict that NewGenIvf Group will post 42.67 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have weighed in on NIVF shares. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research report on Friday, July 24th. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a research report on Saturday, July 4th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Insider Activity

In other news, Director Kong Yiu Cheung acquired 2,500,000 shares of the firm’s stock in a transaction that occurred on Monday, July 27th. The shares were acquired at an average cost of $1.00 per share, with a total value of $2,500,000.00. Following the completion of the purchase, the director directly owned 3,722,223 shares of the company’s stock, valued at $3,722,223. The trade was a 204.55% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing.